|1.||Feige, Jean-Jacques: 5 articles (08/2015 - 04/2006)|
|2.||Goi, Takanori: 5 articles (05/2015 - 03/2004)|
|3.||Yamaguchi, Akio: 5 articles (05/2015 - 03/2004)|
|4.||Alfaidy, Nadia: 4 articles (08/2015 - 04/2006)|
|5.||Hirono, Yasuo: 4 articles (05/2015 - 03/2004)|
|6.||Alfaidy, N: 4 articles (02/2014 - 05/2012)|
|7.||Benharouga, M: 4 articles (02/2014 - 05/2012)|
|8.||Nakazawa, Toshiyuki: 3 articles (05/2015 - 02/2013)|
|9.||Salomon, A: 3 articles (02/2014 - 05/2012)|
|10.||Sergent, F: 3 articles (02/2014 - 05/2012)|
|1.||Pituitary Neoplasms (Pituitary Adenoma)
10/01/2010 - "In this study, we investigated by immunohistochemistry the expression of EG-VEGF in 2 samples of normal adenohypophysis and 43 bioptic samples of pituitary adenoma. "
10/01/2010 - "On the basis of our data showing a marked decrease in the expression of EG-VEGF in pituitary adenoma, with the exception of LH-secreting adenomas, we suggest that LH might be involved in the induction of EG-VEGF secretion."
10/01/2010 - "The results of this study for the first time demonstrate a down-regulation of EG-VEGF expression in human pituitary adenoma as compared to normal adenohypophysis, suggesting an impaired function of the neoplastic cells in terms of hormone release in the blood stream, as a consequence of impaired tumor angiogenesis in the tumor. "
04/01/2015 - "The analysis of EG-VEGF expression in ovarian tumors points out the relationship between the enhanced potential for tumor angiogenesis and the tumor aggressivity."
04/01/2015 - "Significant differences were registered between the EG-VEGF positive or negative expression and tumor stage and histological subtypes, respectively. "
04/01/2015 - "To prove the presence of EG-VEGF in tumor ovary and to analyze its involvement in the ovarian carcinogenesis, as promoter of angiogenesis, in relationship with the clinicopathological prognostic factors and survival. "
12/01/2013 - "Prokineticin 1 expression in gastrointestinal tumors."
01/01/2012 - "We found a strong correlation between the expression of EG-VEGF at protein level and tumor stage, grade, and microscopic type. "
|4.||Colorectal Neoplasms (Colorectal Cancer)
12/01/2007 - "In this study, we investigated the expression of EG-VEGF in colorectal cancer, the relationship between its expression and clinicopathological factors, and the in vitro activity of EG-VEGF transfectants. "
05/01/2015 - "Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer."
12/01/2007 - "We speculate that, in colorectal cancers, the EG-VEGF gene functions as an important factor in angiogenesis in primary and metastatic lesions, and consider that it is useful as a novel prognostic factor. "
12/01/2007 - "We determined expression levels of EG-VEGF in 113 advanced colorectal cancers resected in our hospital by quantitative PCR, and compared the expression levels and clinicopathological findings by multivariate analyses. "
03/15/2004 - "The expression of EG-VEGF was confirmed in all of the colorectal cancer cell lines. "
|5.||Hepatocellular Carcinoma (Hepatoma)
02/28/2008 - "To study the implication of prokineticin 1 (PK1/EG-VEGF) and prokineticin 2 (PK2/Bv8) in hepatocellular carcinoma angiogenesis. "
09/01/2006 - "The aim of the present study was to detect the correlation between the expression of vascular endothelial growth factor (VEGF), angiopoietin 2 (Ang2), ephrinB2 and endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and carcinogenesis or portal vein tumor thrombus (PVTT) formation in human hepatocellular carcinoma (HCC). "
|1.||Endocrine-Gland-Derived Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor, Endocrine Gland Derived)
|2.||Messenger RNA (mRNA)
|3.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|4.||Angiogenesis Inducing Agents (Angiogenesis Factor)
|9.||RNA-Directed DNA Polymerase (Reverse Transcriptase)
|10.||Ovarian epithelial cancer
|3.||Drug Therapy (Chemotherapy)